Market Vectors® Biotech ETF (BBH)

135.10
Delayed Data
As of Jul 02
 -0.25 / -0.18%
Today’s Change
91.45
Today|||52-Week Range
141.33
+17.09%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors ® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for Market Vectors® Biotech ETF.

Performance

1 month+1.29% 3 years+41.07%
3 months+5.52% 5 years--
1 year+37.01% Since inception+46.39%
Data through 07/03/2015

Quote Details

Previous close$135.35
Open day’s range134.47 – 135.65
Net asset value (NAV)135.09 (07/02/2015)
Daily volume76,389
Average volume (3 months)121,196
Data as of 07/02/2015

Peer Comparisonvs. Health ETFs

 BBHCategory
Performance 5-yr return--+22.89%
Expense Gross exp ratio0.41%0.47%
Risk 5 year sharpe ratio--1.68
Net assets$814.2M$1.9B
Average market cap$39.3B$38.6B
Average P/E25.024.7
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
PPH Market Vectors® Pharmaceutical ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences15.73%
AMGN Amgen11.65%
CELG Celgene10.49%
BIIB Biogen7.95%
REGN Regeneron Pharmaceuticals5.92%
BMRN Biomarin Pharmaceutical Inc4.77%
ILMN Illumina Inc4.75%
VRTX Vertex Pharmaceuticals Inc4.55%
INCY Incyte Corp4.35%
ALXN Alexion Pharmaceuticals Inc4.05%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers